Sofinnova Investments, Inc. Inozyme Pharma, Inc. Transaction History
Sofinnova Investments, Inc.
- $1.23 Billion
- Q4 2024
A detailed history of Sofinnova Investments, Inc. transactions in Inozyme Pharma, Inc. stock. As of the latest transaction made, Sofinnova Investments, Inc. holds 4,280,308 shares of INZY stock, worth $5.31 Million. This represents 0.97% of its overall portfolio holdings.
Number of Shares
4,280,308
Previous 4,280,308
-0.0%
Holding current value
$5.31 Million
Previous $22.4 Million
47.04%
% of portfolio
0.97%
Previous 2.12%
Shares
3 transactions
Others Institutions Holding INZY
# of Institutions
104Shares Held
50.7MCall Options Held
2.6KPut Options Held
5.1K-
Adage Capital Partners Gp, L.L.C. Boston, MA5.16MShares$6.4 Million0.03% of portfolio
-
Pivotal Bio Venture Partners Investment Advisor LLC San Francisco, CA4.49MShares$5.57 Million11.45% of portfolio
-
Affinity Asset Advisors, LLC New York, NY3.97MShares$4.93 Million1.97% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD3.86MShares$4.79 Million0.43% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$4.15 Million0.0% of portfolio
About Inozyme Pharma, Inc.
- Ticker INZY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,145,700
- Market Cap $49.8M
- Description
- Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, ...